109 HR 5416 IH: Valley Fever Vaccine Development U.S. House of Representatives 2006-05-18 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I 109th CONGRESS 2d Session H. R. 5416 IN THE HOUSE OF REPRESENTATIVES May 18, 2006 Mr. Thomas introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To provide for grants to conduct research toward the development of a vaccine against Valley Fever.

1.

Short title

This Act may be cited as the Valley Fever Vaccine Development Act.

2.

Grants for research on vaccine against Valley Fever

(a)

In general

In supporting research on the development of vaccines against human diseases, the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, shall make grants for the purpose of conducting research toward the development of a vaccine against coccidioidomycosis (commonly known as Valley Fever). (b)

Sunset

No grant may be made under subsection (a) on or after October 1, 2012. The preceding sentence does not have any legal effect on payments under grants for which amounts appropriated under subsection (c) were obligated prior to such date. (c)

Authorization of appropriations

For the purpose of making grants under subsection (a), there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2007 through 2012.